跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 136 条关于
“FEV1”
全部
136
临床试验
56
药物
9
机构
0
资讯
71
10个月前
Trikafta Shows Sustained Anti-Inflammatory Effects in Cystic Fibrosis Patients Through 2.5 Years
去年
High Blood Eosinophils and FeNO Levels Predict Better Dupilumab Response in Moderate-to-Severe Asthma
去年
Study on Inhaled Fexlamose for Treating Moderate to Severe COPD in Adults
去年
Rademikibart Shows Unprecedented 420mL Lung Function Improvement in Phase 2 Asthma Trial
3个月前
No Link Between Cat Ownership and Asthma Flare-Ups in Children, Swedish Registry Study Finds
7个月前
AstraZeneca's BREZTRI Shows Significant Lung Function Improvements in Phase III Asthma Trials
2年前
BiomX's BX004 Shows Promise in Phase 1b/2a Trial for Cystic Fibrosis Patients with Pseudomonas aeruginosa Infections
去年
Race-Based Correction in COPD Trials May Exclude Minority Groups
去年
Verona Pharma's Ensifentrine Shows Promise in COPD and COVID-19 Trials
去年
Phase 2 Trial Evaluates Host-Directed Therapies for Rifampicin-Resistant Tuberculosis
第 1 页,共 8 页
上一页
下一页